Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Rang in aandelen #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Aandeelprijs
$2.35
Laatst gesynchroniseerd: 2022-09-07
Marktkapitalisatie
$162.94K
Verandering (1 dag)
2.17%
Verandering (1 jaar)
0.00%
Land
US
Handel Brickell Biotech, Inc. (BBI)

Categorie

Prijs BBI met de marktkapitalisatie van B
Brickell Biotech, Inc. Brickell Biotech, Inc.
BBI
$2.35
Marktkapitalisatie van Brickell Biotech, Inc.(BBI)
Marktkapitalisatie: $162.94K
Vanaf August 2026 heeft Brickell Biotech, Inc. een marktkapitalisatie van $162.94K. Dit maakt Brickell Biotech, Inc. volgens onze gegevens het 40377th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Brickell Biotech, Inc. van 2019 tot 2026
BBI vergeleken met de top 5 populairste stocks
Prijs voor BBI Aandeel B Marktkapitalisatie van B uitslagen
Brickell Biotech, Inc. Brickell Biotech, Inc.
$78,884,530 $162.94K
$5.470T +3,356,788,414.27%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$64,426,434 $162.94K
$4.467T +2,741,550,267.91%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$60,205,180 $162.94K
$4.174T +2,561,922,456.83%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$53,364,447 $162.94K
$3.700T +2,270,827,439.47%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$41,166,821 $162.94K
$2.854T +1,751,779,516.19%